Cover Image
Market Research Report

Insulin Patch Pumps

Published by Greystone Research Associates Product code 223039
Published Content info
Delivery time: 1-2 business days
Not Available
Back to Top
Insulin Patch Pumps
Published: November 9, 2011 Content info:

This publication has been discontinued on July 3, 2017.


Greystone Research Associates is pleased to announce the publication of a new market study. Insulin Patch Pumps: Devices, Markets, Players and Prospects is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for integrated devices that couple a transdermal drug device format with an active delivery technology. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

User Friendly Devices and Improved Patient Compliance

The collapse of the inhaled insulin market in 2008 has resulted in programs focused on alternative insulin delivery technologies. It now appears that the patch pump - a device that represents the convergence of a transdermal reservoir system with an energy source and control technology - will be the next generation in the evolution in patient-friendly insulin administration. With four FDA-approved insulin patch pump products and twice as many serious development-stage devices, the next 36 months will be critical to market sector participants wishing to ascend to a leadership position in the market segment. With no room for post-market missteps, product reliability, ease-of-use and patient acceptance will be essential for market success.

Feature Summary

  • Analyzes and evaluates patch pump products and assesses the market potential for existing and pipeline products
  • Analyzes product design strategies, technologies and market development issues
  • Provides detailed descriptions of insulin patch pump market segments, market demographics, and business strategies
  • Provides market data and forecasts to 2015
  • Profiles patch pump product companies, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of IP and design partnerships on active insulin patch products
  • Evaluates the impact of economic, technology, and regulatory factors on insulin delivery markets

Report Format and Availability

This report is available in electronic format.

Table of Contents
Product Code: DPP395B

Table of Contents

Executive Summary

Diabetes Management Market Dynamics

  • Shifting Insulin Delivery Markets
  • Demand Drivers
    • Demographic Shifts
    • Managed Care Initiatives
    • Growth in Home Healthcare
    • Patient Compliance
  • Technology Market Drivers
  • Competitive Landscape

Patch Pump Device Strategies

  • Device/System Architecture
  • Drug Delivery Mechanism
  • Drug Reservoirs
  • Sized Patch Pumps
  • Handheld Remote Electronics
  • Accuracy and Dosing Variability
  • Alerts and Patient Notification
  • Special Features

FDA-Approved Insulin Patch Pumps - Analysis and Market Data

  • Finesse
  • OmniPod
  • Solo
  • V-Go

Development-Stage Insulin Patch Pumps - Assessments & Forecasts

  • Cellnovo
  • CeQur
  • Freehand
  • Jewel Pump
  • Medipacs
  • PassPort
  • Sensile Medical
  • Spring Hybrid Pump
  • SteadyMed

Market Factors

  • Regulations
    • U.S.
    • International
  • Trials & Approval
  • IP and Product Positioning

Sector Participant Company Profiles

Back to Top